Infacol suspension for oral use 40 mg/ml. 50 ml. vial

Description

Infacol Storage
active substance: simethicone;

1 ml of suspension contains simethicone 40 mg;

Excipients: saccharin sodium, hydroxypropylmethylcellulose, orange flavor, methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), purified water.

Infacol Dosage form
The suspension is oral.

Main physical and chemical properties: homogeneous translucent suspension without visible inclusions with orange odor.

Infacol Pharmacotherapeutic group
Remedies used in functional gastrointestinal disorders. Silicones.

Code ATX A0ZA X13.

Pharmacological properties

Pharmacodynamics.

Simethicone – a stable surfactant polymethyloxane, defoamer. It changes the surface tension of the gas bubbles formed in the stomach and intestinal mucosa, and thus they break down or combine, which facilitates their removal. The released gases are absorbed by the intestinal wall or removed due to intestinal peristalsis. Simethicone removes gas bubbles only physically, does not enter into chemical reactions and is chemically inert.

Pharmacokinetics.

Simethicone is not absorbed orally and is excreted unchanged in the intestine.

Indication
Symptomatic treatment of gastrointestinal complaints related to flatulence, such as abdominal pain, colic, bloating, flatulence.

Contraindication
Hypersensitivity to simethicone or to any of the excipients.

Intestinal obstruction, obstructive diseases of the gastrointestinal tract.

Interaction with other medicinal products and other forms of interaction
Levothyroxine may bind to simethicone. Absorption of levothyroxine in the intestine may be impaired when co-administered with simethicone.